DI
ABBV icon

Disciplined Investments’s AbbVie ABBV Stock Holding History

Disciplined Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$572K Buy
2,271
+1
+0% +$215 0.18% 81
2026
Q1 		$494K Buy
2,270
+1,251
+123% +$278K 0.18% 86
2025
Q4 		$233K Buy
+1,019
New +$232K 0.09% 112
2023
Q3 		– Sell
-602
Closed -$81.1K – 112
2023
Q2 		$81.1K Sell
602
-34
-5% -$4.99K 0.04% 167
2023
Q1 		$101K Sell
636
-24
-4% -$3.67K 0.04% 166
2022
Q4 		$107K Sell
660
-85
-11% -$13K 0.05% 137
2022
Q3 		$100K Sell
745
-47
-6% -$6.74K 0.05% 158
2022
Q2 		$121K Buy
792
+31
+4% +$4.74K 0.05% 150
2022
Q1 		$123K Sell
761
-47
-6% -$6.83K 0.05% 153
2021
Q4 		$109K Buy
808
+320
+66% +$37.8K 0.05% 148
2021
Q3 		$53K Hold
488
– – 0.03% 197
2021
Q2 		$55K Buy
488
+110
+29% +$12.4K 0.03% 190
2021
Q1 		$41K Buy
378
+12
+3% +$1.28K 0.02% 189
2020
Q4 		$39K Hold
366
– – 0.03% 164
2020
Q3 		$32K Sell
366
-437
-54% -$41.1K 0.02% 184
2020
Q2 		$79K Hold
803
– – 0.06% 129
2020
Q1 		$61K Buy
803
+12
+2% +$1.02K 0.06% 137
2019
Q4 		$70K Buy
+791
New +$65.7K 0.06% 141

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Disciplined Investments's ABBV Position: Q2 2026 in Review

Disciplined Investments increased its AbbVie (ABBV) stake by 0.04% in Q2 2026, buying an estimated $215 and bringing the position to 2,271 shares worth $572K. The position accounts for 0.18% of the portfolio, ranked #81.

Disciplined Investments first reported a position in ABBV in Q4 2019 and has held it in 18 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Disciplined Investments held 2,271 shares of AbbVie worth $572K as of Q2 2026.
  • Disciplined Investments bought 1 AbbVie share in Q2 2026, an estimated $215.
  • AbbVie made up 0.18% of Disciplined Investments's portfolio in Q2 2026, its #81 holding.
  • Disciplined Investments first reported a position in AbbVie in Q4 2019 and has held it in 18 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Disciplined Investments's 13F filing for Q2 2026, filed 7 Aug 2026.